Remove mymd-pharmaceuticals-and-charles-river-present-positive-data-for-next-generation-oral-tnf-�-inhibitor-mymd-1-in-rheumatoid-arthritis
article thumbnail

MyMD Pharmaceuticals® and Charles River Present Positive Data for Next Generation, Oral TNF-? Inhibitor MYMD-1® in Rheumatoid Arthritis

Medical Marijuana Program Connection

BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc.® ® (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage biopharmaceutical company developing groundbreaking therapies for the. Read More